Search
  • mmahomed2

Phase I SBIR grant from the National Institute of Arthritis

Valitor has been awarded a Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project will support the translation platform technology to generate long-acting drug products that can be used to treat inflammatory joint diseases.

0 views

© Valitor, Inc 2020

  • LinkedIn - White Circle